Ajay K. Nooka, MD, MPH, FACP

P2401022

Specialty

Dr. Nooka specializes in the treatment of patients with multiple myeloma as part of the hematology care team at Winship Cancer Institute.

Titles and Roles

Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Associate Director of Clinical Research
Winship Cancer Institute of Emory University
Director, Myeloma Program, Department of Hematology and Medical Oncology
Emory University School of Medicine
Scientific Director, Winship Data and Technology Applications Shared Resource
Winship Cancer Institute of Emory University
Hematologist
Multiple Myeloma
Amyloidosis & Other Plasma Cell Disorders
Bone Marrow and Stem Cell Transplant Center
Phase I Clinical Trials Unit
Research Program
Cancer Prevention and Control

Biography

Ajay Kumar Nooka, MD, MPH, FACP, is professor, and serves as director of the Myeloma Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Nooka serves as associate director of clinical research and as scientific director of the Winship Data and Technology Applications Shared Resource at Winship Cancer Institute of Emory University. An Emory Healthcare network physician since 2011, Dr. Nooka is a board certified hematologist specializing in the treatment of patients with multiple myeloma.

Dr. Nooka is a clinical member of the Cancer Prevention and Control Research Program at Winship Cancer Institute of Emory University. He serves on the steering committee of the Multiple Myeloma Research Consortium.

Education

Dr. Nooka attended Medical School at the Andhra Medical College in Visakhapatnam, India. He earned his Master's in Public Health at the University of Texas School of Public Health. He then went on to complete his residency at Canton Medical Education Foundation in Canton, Ohio. He did his fellowship at the Winship Cancer Institute of Emory University in Atlanta, GA.

Research

Dr. Nooka's research interests include integrating genomic and clinical data on a uniform platform; interpreting data in a meaningful way to risk-stratify myeloma; and evaluating newer myeloma therapeutic strategies aimed at prolonging survival in myeloma patients. He also focuses on cancer epidemiology.

  • Below is a listing of current federal grants for the above principal investigator.

    GrantNumberTitle

Publications

Dr. Nooka serves on the editorial board for The American Journal of Clinical Oncology, Journal of Hematological Malignancies, Lymphoma and Chronic Lymphocytic Leukemias, and serves as section editor of hematologic malignancies for Cancer. He is an ad hoc journal reviewer for Annals of Oncology, Oncology, Leukemia Research, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, European Journal of Cancer, Current Oncology, Indian Journal of Medical Research and International Journal of Hematology.

  • PublicationsPublication Date

Awards

Dr. Nooka is the recipient of the following awards:

  • Multiple Myeloma Research Foundation
  • International Myeloma Foundation (IMF) Special Research Grant, 2014
  • Multiple Myeloma Research Foundation (MMRF) Accelerator Award, 2013
  • Conquer Foundation ASCO Merit Award, Chicago, IL, 2011
  • Fellowship of American College of Physicians, 2011
  • AACR/ASCO Workshop: Methods in Clinical Cancer Research, Vail, CO, 2010
  • Frederick C. Whittier Excellence in Research Award, Canton Medical Education Foundation, OH, 2008
  • Rochfort Scholarship, Emory University, GA, 2008
  • Frederick C. Whittier Excellence in Research Award, Canton Medical Education Foundation, OH, 2007
  • American College of Physicians National Abstracts Competition, San Diego, CA, 2007
  • D. Jack Kilian Memorial Scholarship, UTSPH, Houston, TX, 2003

Additional Websites

Cascade Link   TOP